S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Monteverde & Associates Scrutinizes Four Major Corporate Mergers

With crucial shareholder votes looming in early September, New York-based law firm Monteverde & Associates PC has launched formal investigations into four high-profile mergers. Attorney Juan Monteverde is currently reviewing the terms of proposed deals involving Dominion Energy, NextEra Energy, Arcosa, and Selectis Health for potential shareholder grievances.

Monteverde & Associates Scrutinizes Four Major Corporate Mergers
Photo: Bio & News

The firm is scrutinizing the acquisition of Dominion Energy, Inc. (NYSE: D) by NextEra Energy, Inc. (NYSE: NEE), where Dominion shareholders are slated to receive 0.8138 shares of NextEra for each share held. Upon completion, NextEra investors are expected to control approximately 74.5% of the combined entity. Shareholders are scheduled to cast their votes on this transaction on September 3, 2026.

Simultaneously, the firm is investigating the sale of Arcosa, Inc. (NYSE: ACA) to CRH Americas, Inc., a deal offering shareholders $150.00 per share in cash, with a vote set for September 4, 2026. Additionally, the firm is reviewing the sale of Selectis Health, Inc. (OTCMKTS: GBCS) to Black Pearl Equities II, LLC, which provides for a cash consideration of $5.75 per share.

Monteverde & Associates, which maintains offices in the Empire State Building, encourages investors concerned about the fairness of these transactions to seek legal consultation. The firm has positioned itself as a specialist in securities class actions, citing its history of recoveries in both trial and appellate courts. Shareholders seeking further information regarding their rights ahead of the upcoming deadlines can contact the firm directly.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!